Page last updated: 2024-10-30

metformin and Fetal Distress

metformin has been researched along with Fetal Distress in 1 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Fetal Distress: A nonreassuring fetal status (NRFS) indicating that the FETUS is compromised (American College of Obstetricians and Gynecologists 1988). It can be identified by sub-optimal values in FETAL HEART RATE; oxygenation of FETAL BLOOD; and other parameters.

Research Excerpts

ExcerptRelevanceReference
"Even normal pregnancy is characterized by relative insulin resistance and glucose intolerance."3.01Prophylactic metformin after antenatal corticosteroids (PROMAC): a double blind randomized controlled trial. ( Hong, JGS; Kamarudin, M; Omar, SZ; Tan, PC, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Hong, JGS1
Tan, PC1
Kamarudin, M1
Omar, SZ1

Trials

1 trial available for metformin and Fetal Distress

ArticleYear
Prophylactic metformin after antenatal corticosteroids (PROMAC): a double blind randomized controlled trial.
    BMC pregnancy and childbirth, 2021, Feb-15, Volume: 21, Issue:1

    Topics: Adult; Dexamethasone; Diabetes, Gestational; Double-Blind Method; Female; Fetal Distress; Glucocorti

2021